9/12 5:30 pm - 8:30 pm
HBA presents 'Putting Academia-Industry Research Partnerships to Work.' Novartis, 1 Health Plaza, East Hanover, NJ more
9/24 4:00 pm - 6:00 pm
CURE presents healthcare investment banker Anthony Gibney of Leerink Swann. Yale Anlyan Center, 300 Cedar Street, New Haven more
10/1 4:00 pm - 6:00 pm
CURE/Yale BioHaven presents Trevi Therapeutics. Anlyan Center, 300 Cedar Street, New Haven. Watch for details.
10/8-9 12th annual BIO Investor Forum. The Palace Hotel, San Francisco more
10/15 6:00 pm - 9:30 pm
HBA presents Women's Healthcare Innovation and Leadership Showcase. Sanofi Campus, 55 Corporate Drive Auditorium, Bridgewater, NJ more
11/7 10:00 am - 3:00 pm
CT Innovation Summit. Mentor meetings, awards ceremony, and more. Co-sponsored by CURE. Oakdale Theater, Wallingford more
11/11-13 The BIO Convention in China. National Convention Center, Beijing more
12/3 5:45 pm - 7:30 pm
CURE Holiday Party. 'The best networking in town.' Café George, 300 George Street, New Haven. Save the Date!

Cost-saving discounts for CURE members!
CURE members can now receive discounts on various products and services, such as lab supplies, shipping services, and gases more

Health Sciences International, Inc.
25 Saltus Drive
Old Saybrook, CT 06475

Phone: 860-339-5272
Website: http://hsiresearch.org

David M. Shearer, MD - President & CEO - dshearer@hsiresearch.org

General Information
Health Sciences International, Inc. a clinical research organization established in 1997, comes to Connecticut with expertise in the conduct of Phase I-IV clinical trials.

Research Activities
Health Sciences International, Inc. (HSI), a thirteen year old comprehensive Clinical Research Organization (CRO) comes to Connecticut. HSI has a unique business model which assures that Phase I-IV clinical trials, in multiple therapeutic areas, meet milestone timelines while adhering to enforceable SOPs, GCP, Standards of the Industry and CFR/ ICH Guidelines. HSI worldwide capabilities include: Protocol and CRF Design, Medical Affairs, Medical Monitoring, Clinical Operations, Project Management, Drug Research & Development, Safety and Pharmacovigilance, Ambulatory BP & EKG Monitoring, Medical Writing, Medical Science Liaisons, Data Management and Biostatistics, Site Selection and Feasibility, REMS/ registry/Health Outcome Systems, creating customized and intelligent solutions that assure deliverables to meet the goals of our clients while reducing time to market and overhead expenses. HSI has a commitment to patient safety through professional Educational Marketing and supportive direct to consumer capabilities, conferences, seminars and CME/ CEU accreditation. HSI has a stellar reputation in the industry that excels in Leadership, Integrity, Vision and Excellence (LIVE) and prides itself with “first-rate” collaborative partners such as BioClinica.